These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 10229852

  • 1. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
    Yasukawa M, Ohminami H, Yakushijin Y, Arai J, Hasegawa A, Ishida Y, Fujita S.
    J Immunol; 1999 May 15; 162(10):6100-6. PubMed ID: 10229852
    [Abstract] [Full Text] [Related]

  • 2. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.
    Yasukawa M, Ohminami H, Arai J, Kasahara Y, Ishida Y, Fujita S.
    Blood; 2000 Apr 01; 95(7):2352-5. PubMed ID: 10733506
    [Abstract] [Full Text] [Related]

  • 3. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K.
    J Immunol; 1996 May 15; 156(10):3678-86. PubMed ID: 8621902
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A, Gamen S, Alava MA, Schmitt-Verhulst AM, Piñeiro A, Naval J.
    J Immunol; 1997 Mar 01; 158(5):1999-2006. PubMed ID: 9036942
    [Abstract] [Full Text] [Related]

  • 5. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM, Bement TT, Xu J, Lynch DH, Grabstein KH, Reed SG, Alderson MR.
    J Immunol; 1998 Mar 01; 160(5):2374-9. PubMed ID: 9498779
    [Abstract] [Full Text] [Related]

  • 6. Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide.
    Ohminami H, Yasukawa M, Kaneko S, Yakushijin Y, Abe Y, Kasahara Y, Ishida Y, Fujita S.
    Blood; 1999 Feb 01; 93(3):925-35. PubMed ID: 9920842
    [Abstract] [Full Text] [Related]

  • 7. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS, Engelhard VH.
    J Immunol; 1996 Jan 01; 156(1):153-9. PubMed ID: 8598456
    [Abstract] [Full Text] [Related]

  • 8. Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis.
    Vergelli M, Hemmer B, Muraro PA, Tranquill L, Biddison WE, Sarin A, McFarland HF, Martin R.
    J Immunol; 1997 Mar 15; 158(6):2756-61. PubMed ID: 9058810
    [Abstract] [Full Text] [Related]

  • 9. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G, Balkow S, Schimmer S, Schepers K, Simon MM, Dittmer U.
    Virology; 2004 Dec 20; 330(2):365-74. PubMed ID: 15567431
    [Abstract] [Full Text] [Related]

  • 10. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.
    Khanolkar A, Yagita H, Cannon MJ.
    Virology; 2001 Aug 15; 287(1):79-88. PubMed ID: 11504544
    [Abstract] [Full Text] [Related]

  • 11. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F, Ishii E, Kojima K, Hasegawa A, Azuma T, Hirose S, Suga N, Mitsudome A, Zaitsu M, Ishida Y, Shirakata Y, Sayama K, Hashimoto K, Yasukawa M.
    J Immunol; 2003 Feb 15; 170(4):2205-13. PubMed ID: 12574394
    [Abstract] [Full Text] [Related]

  • 12. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K, Akashi A, Arai S.
    Cell Immunol; 1998 May 01; 185(2):114-22. PubMed ID: 9636689
    [Abstract] [Full Text] [Related]

  • 13. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Jul 01; 133(1):422-7. PubMed ID: 6609990
    [Abstract] [Full Text] [Related]

  • 14. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q, Burton RL, Pollok KE, Emanuel DJ, Lucas KG.
    Cell Immunol; 1999 Aug 01; 195(2):81-8. PubMed ID: 10448007
    [Abstract] [Full Text] [Related]

  • 15. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
    Miskovsky EP, Liu AY, Pavlat W, Viveen R, Stanhope PE, Finzi D, Fox WM, Hruban RH, Podack ER, Siliciano RF.
    J Immunol; 1994 Sep 15; 153(6):2787-99. PubMed ID: 7915742
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP, Hoskin DW.
    J Immunol; 1997 Nov 15; 159(10):4700-7. PubMed ID: 9366393
    [Abstract] [Full Text] [Related]

  • 17. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.
    Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M.
    J Immunol; 1997 Jun 01; 158(11):5283-91. PubMed ID: 9164947
    [Abstract] [Full Text] [Related]

  • 18. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT, Morgan DJ, Krahl T, Ko A, Sarvetnick N, Sherman LA.
    J Immunol; 1999 Oct 15; 163(8):4335-41. PubMed ID: 10510373
    [Abstract] [Full Text] [Related]

  • 19. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT, Dinglasan RD, Krishnamurthy B, Gullo CA, Graham MB, Braciale VL.
    J Immunol; 1997 Jun 15; 158(12):5612-8. PubMed ID: 9190908
    [Abstract] [Full Text] [Related]

  • 20. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y, Thoburn CJ, Bright EC, Hess AD.
    Biol Blood Marrow Transplant; 2004 Mar 15; 10(3):156-70. PubMed ID: 14993881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.